不同放疗剂量应用于晚期肺癌患者近远期疗效分析
CSTR:
作者:
作者单位:

(中国人民武装警察部队河南省总队医院,河南 郑州 450000)

作者简介:

谷美林,女,主管技师,主要研究方向是肿瘤放射治疗。

通讯作者:

中图分类号:

R 734.2

基金项目:


Analysis of Short-term and Long-term Effects of Different Doses of Radiotherapy on Patients with Advanced Lung Cancer
Author:
Affiliation:

(Chinese People's Armed Police General Hospital, Henan Zhengzhou 450000)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    〔摘 要〕 目的:探讨不同放疗剂量应用于晚期肺癌患者的近远期疗效。方法:选取中国人民武装警察部队河南省 总队医院2018年9月至2021年1月期间收治的81例晚期肺癌患者,按照随机数字表法分为对照组40例和观察组41例。 对照组予以高剂量放疗,观察组予以低剂量放疗,观察两组患者的近远期疗效、肿瘤标志物、免疫功能及不良反应发 生情况。结果:观察组总有效率 78.05 %,对照组总有效率 70.00 %,两组比较差异无统计学意义(P > 0.05);两组 复发率、死亡率比较,差异无统计学意义(P > 0.05);两组放疗后糖类抗原 125(CA125)、癌胚抗原(CEA)以 及细胞角蛋白 19 片段抗原 21–1(CYFRA21–1)水平均低于放疗前,两组比较差异无统计学意义(P > 0.05);两组 放疗后 CD4+、CD3+ 水平均低于放疗前,而观察组高于对照组,CD8+ 水平均高于治疗前,而观察组低于对照组,差 异具有统计学意义(P<0.05);观察组不良反应发生率7.32 %,低于对照组25.00 %,差异具有统计学意义(P<0.05)。 结论:低剂量放疗应用于晚期肺癌患者能够降低肿瘤标志物含量,提高免疫功能,降低不良反应发生率,且与高剂量 放疗的近远期疗效相近。

    Abstract:

    〔Abstract〕 Objective To investigate the short-term and long-term effects of different radiotherapy doses in patients with advanced lung cancer. Methods A total of 81 patients with advanced lung cancer admitted to Henan Provincial Armed Police Corps Hospital from September 2018 to January 2021 were selected and divided into a control group with 40 cases and an observation group, with 41 cases according to the random number table method. The control group was given high-dose radiotherapy, the observation group was given low_x0002_dose radiotherapy, and the short-term and long-term efficacy, tumor markers, immune function and the occurrence of adverse reactions were observed in the two groups. Results The total effective rate was 78.05% in the observation group and 70.00% in the control group, and there was no significant difference between the two groups (P > 0.05). There was no significant difference in recurrence rate and mortality between the two groups (P > 0.05). The levels of carbohydrate antigen 125 (CA125), carcinoembryonic antigen (CEA) and cytokeratin 19 fragment antigen 21-1 (CYFRA21-1) in the two groups after radiotherapy were lower than those before radiotherapy, and there was no statistical significance between the two groups (P > 0.05). The levels of CD4+ and CD3+ in the two groups after radiotherapy were lower than before treatment, while the levels of the observation group were higher than those of the control group, and the level of CD8+ was higher than before treatment, while the level of CD8+ of the observation group was lower than the that of the control group, the differences were statistically significant (P < 0.05). The incidence of adverse reactions in the observation group was 7.32%, lower than 25.00% in the control group, and the difference was statistically significant (P < 0.05). Conclusion The application of low-dose radiotherapy to patients with advanced lung cancer can reduce the content of tumor markers, improve immune function, and reduce the incidence of adverse reactions, and the short-term and long-term efficacy of low-dose radiotherapy is comparable to that of high-dose radiotherapy

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-02-18
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-08-22
  • 出版日期:
文章二维码
特别声明

近期有不法分子冒充我刊名义给作者打电话或发邮件,编造各种理由要求添加微信或QQ、伪造复制我刊编辑部公章发放假冒录用通知书等等各种方式试图骗取作者钱财。为强化编辑部工作规范,加强单位公章管理,维护作者的正当权益和财产利益, 我刊在此郑重声明:(1)编辑部与作者沟通方式为电话和邮件,在本刊唯一官方网站(http:/szzxyjhzz.szrch.com)“联系我们”下拉菜单,或者网站最下端信息栏可以查询),绝对不会要求作者添加微信或QQ。 (2)自2025年2月1日起,注销废除“深圳中西医结合杂志编辑部”电子公章;我刊稿件录用通知调整为加盖编辑部实体公章的纸质文件或其扫描件,录用稿件仅收取合理版面制作费和审稿费,收款单位为“深圳市第二人民医院”对公账户,其他加盖电子公章或涉及私人账户者均为伪造假冒。望广大作者提高警惕,谨防上当受骗。 《深圳中西医结合杂志》编辑部

关闭